Literature DB >> 32242942

The validity of the Canadian clinical scores for occupational asthma in European populations.

Eva Suarthana1,2, Mahsa Taghiakbari1,2, Paramita Saha-Chaudhuri3, Catherine Rifflart4, Hille Suojalehto5, Pirjo Hölttä5, Jolanta Walusiak-Skorupa6, Marta Wiszniewska6, Xavier Muñoz7, Christian Romero-Mesones7, Joaquín Sastre8, Manuel J Rial8, Paul K Henneberger9, Olivier Vandenplas4.   

Abstract

Entities:  

Keywords:  asthma; epidemiology; occupational allergies; prevention

Mesh：

Year:  2020        PMID： 32242942      PMCID： PMC7955651          DOI： 10.1111/all.14294

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  10 in total

Review 1.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

2.  Novel clinical scores for occupational asthma due to exposure to high-molecular-weight agents.

Authors:  Mahsa Taghiakbari; Jacques-André Pralong; Catherine Lemière; Gregory Moullec; Paramita Saha-Chaudhuri; André Cartier; Roberto Castano; Eva Suarthana
Journal:  Occup Environ Med       Date:  2019-04-20       Impact factor: 4.402

Review 3.  Diagnosing occupational asthma.

Authors:  O Vandenplas; H Suojalehto; P Cullinan
Journal:  Clin Exp Allergy       Date:  2017-01       Impact factor: 5.018

4.  Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement.

Authors:  Olivier Vandenplas; Hille Suojalehto; Tor B Aasen; Xaver Baur; P Sherwood Burge; Frederic de Blay; David Fishwick; Jennifer Hoyle; Piero Maestrelli; Xavier Muñoz; Gianna Moscato; Joaquin Sastre; Torben Sigsgaard; Katri Suuronen; Jolanta Walusiak-Skorupa; Paul Cullinan
Journal:  Eur Respir J       Date:  2014-03-06       Impact factor: 16.671

Review 5.  Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.

Authors:  P J Sterk; L M Fabbri; P H Quanjer; D W Cockcroft; P M O'Byrne; S D Anderson; E F Juniper; J L Malo
Journal:  Eur Respir J Suppl       Date:  1993-03

6.  A rapid dosimetric method with controlled tidal breathing for histamine challenge. Repeatability and distribution of bronchial reactivity in a clinical material.

Authors:  A R Sovijärvi; L P Malmberg; K Reinikainen; P Rytilä; H Poppius
Journal:  Chest       Date:  1993-07       Impact factor: 9.410

Review 7.  Occupational asthma in the developing and industrialised world: a review.

Authors:  M F Jeebhay; S Quirce
Journal:  Int J Tuberc Lung Dis       Date:  2007-02       Impact factor: 2.373

8.  Use of specific inhalation challenge in the evaluation of workers at risk for occupational asthma: a survey of pulmonary, allergy, and occupational medicine residency training programs in the United States and Canada.

Authors:  Hector G Ortega; David N Weissman; Deanna L Carter; Daniel Banks
Journal:  Chest       Date:  2002-04       Impact factor: 9.410

9.  Assessing the performance of prediction models: a framework for traditional and novel measures.

Authors:  Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

Review 10.  The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement.

Authors:  Paul D Blanc; Isabella Annesi-Maesano; John R Balmes; Kristin J Cummings; David Fishwick; David Miedinger; Nicola Murgia; Rajen N Naidoo; Carl J Reynolds; Torben Sigsgaard; Kjell Torén; Denis Vinnikov; Carrie A Redlich
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.